SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001280600-19-000051
Filing Date
2019-11-06
Accepted
2019-11-06 07:54:54
Documents
16
Period of Report
2019-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xlrn-20191106form8xk.htm   iXBRL 8-K 50719
2 EXHIBIT 99.1 xlrn-20191106ex991.htm EX-99.1 107787
8 xlrnlogoa31.gif GRAPHIC 11525
  Complete submission text file 0001280600-19-000051.txt   327727

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xlrn-20191106.xsd EX-101.SCH 4603
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xlrn-20191106_cal.xml EX-101.CAL 634
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xlrn-20191106_def.xml EX-101.DEF 1484
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xlrn-20191106_lab.xml EX-101.LAB 26142
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xlrn-20191106_pre.xml EX-101.PRE 13590
9 EXTRACTED XBRL INSTANCE DOCUMENT xlrn-20191106form8xk_htm.xml XML 4296
Mailing Address 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SIDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Filer) CIK: 0001280600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36065 | Film No.: 191195110
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences